General AML

ASCO 2019 | What is the role of low-dose hypomethylating agents in myeloid disorders?

L:

Guillermo Garcia-Manero, MD Anderson Cancer Center, talks to the AML Global Portal (AGP) about the role of low-dose hypomethylating agents in myeloid disorders during the 2019 ASCO Annual Meeting in Chicago.